European Union " high threshold " It is very heavy to refract the internationalized pressure of traditional Chinese medicine

European Union " high threshold " It is very heavy to refract the internationalized pressure of traditional Chinese medicine
With>The deadline date in transition period of 7 is near, Chinese traditional Chinese medicine enterprises want to further expand European Union market, seem to have difficulty moving about.
According to the regulation, during April of 2011, have already been listed on European Union member state traditional plant medicine sold and can continue selling from April 30, 2004, must go on the market and sell after registering according to the regulation procedure of " order " hereafter.
European Union is one of the largest markets of plant medicine in the world, account for 40 of world plant's medicine market share, have attracted much traditional Chinese medicine enterprises to be eager to have a try. But among 7 years, enterprise succeed in registering no of traditional Chinese medicine of China in European Union, break a record. In the face of a lot of one which European Union sets up" The high threshold " ,Whether there could be enterprises at the end stage dash successfully, it is still unknown number.
The medical health product Deputy Chairman of chamber of import and export trade Liu ZhangLin in China expresses when being interviewed by reporter, there must be medical history of over 30 years before registering the application date in European Union in traditional Chinese medicine, use history for 15 years in European Union at least. Because most traditional Chinese medicine are with additive of meal, health product,etc. " The identity " Enter the intersection of European Union and market, so a lot of traditional Chinese medicine enterprise unable to obtain, sell, prove for a certain product. Probably there are 100 kinds of to can offer traditional Chinese medicine that has used history to prove for 15 years in European Union at present.
In addition, the reporter knows, traditional Chinese medicine enterprises want to be registered qualification on European Union market, still need to face the high cost.
An insider tells reporters, register according to the regulation of European Union, the registered cost of single Chinese medicine is about 100 ten thousand yuan, and a traditional Chinese medicine enterprise generally have a plurality of varieties, G M P (the standardard management of quality of production of medicines) after add Service charge and hardware investment of authorizing etc., it will be a large sum of costs.
"The achievement of the markets of this and domestic most traditional Chinese medicine enterprises does not accord with, in addition, recent Chinese medicinal materials rise in price again and again, enterprise's pressure multiplication. " The securities medical trade analyst Zhao Bing in Shanghai say.
China throws Guo FanLi, medical trade researcher of advisor, but pointed out too, except traditional Chinese medicine enterprises should deal with the above-mentioned " unalterable quota " ,Still need to face and overcome some " The soft quota " ,Such as the international culture background difference, local's approval and accepting the intensity of the medical result of traditional Chinese medicine,etc..
In fact, the staple market that European Union is not Chinese medicine of our country exports to, the volume of export of Chinese medicine to European Union of our country will be about 1000 ten thousand dollars in 2010, accounting for than only has 0 . 5 % . However, traditional Chinese medicine enterprises are awkward in European Union market experience, refract traditional Chinese medicine enterprise and products and in the weak position in the world again.
"For a long time, Chinese medicine of our country is often kept outside of the door because of being unable to explain their compositions and pharmacology function to foreigners, in addition, domestic G M P has not been in line with international standards yet, has made enterprises walk out intermediate frequency meet with the barriered. " Guo FanLi says.
Shanghai traditional Chinese medicine scientific and technological industry promotes minister Li JiZong of advancing department of centre to show too, it is registered though our country is low to the trade export share of European Union market, this time " to make " Have a limited effect on market of domestic traditional Chinese medicine in a short time at the specified date, but medical enterprises do not lack all sorts of challenges and pressures on the road to head out.
Li JiZong proposes, enterprises can cooperate with overseas medicine enterprise through strengthening, are familiar with operation procedures and characteristics of the overseas market progressively, after getting to these markets ripely gradually, introduce the products, the result will be better.
In addition, some experts propose the medical enterprises of our country step up perfecting the exercises to benefit the internal organs, promote the product quality and competitiveness of market, and study and analyze history and culture, law of various countries,etc., know yourself as well as the enemy conscientiously.
What deserves to be mentioned is, though European Union legal provision after the plant medicine products registered are in transition period unable in other name ( For instance food additive, health food,etc.) Market sell in European Union, the intersection of China and medical the intersection of health product and by the look of situation that European Union relevant department has known chamber of import and export trade at present, European Union has not carried on strict definition and division to it yet.
"Because the functions of a lot of plant products have variety, can already be used as food additive, can also used in into medicines, what it is concrete products should include in which kind of channel gone on and manage, generally asserted according to relevant regulation cases by member states, if member states assert this product is medicines, this product can't be sold in other name. " Liu ZhangLin says. So, it still remains to be seen what course should follow on the market in European Union of traditional Chinese medicine.
|